OrganaBio launches new division to meet growing demand for decentralized clinical trial support

OrganaBio, the Contract Technology Development and Manufacturing Organization (CTDMO) specializing in solutions for cell and immunotherapy development, today announces the official launch of Cell Processing and Cryopreservation (CPC) Services, a new division of OrganaBio.

Related Keywords

Justin Irizarry ,Priya Baraniak ,Lily Ramsey ,Manufacturing Organization ,Contract Technology Development ,Cell Processing ,Gene Therapy ,Clinical Trial ,Flood ,Dancer ,Fell ,Gene ,Immunotherapy ,Influenza ,Manufacturing ,Pandemic ,Research ,Espiratory ,Respiratory Syncytial Virus ,Cars ,Ars Cov 2 ,Technology ,Vaccine ,Virus ,